Spyre Therapeutics Inc (SYRE)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 174k | 168k | 198k | 688k | 0 | 0 | 0 | 0 |
| Operating Income | -18.76M | -19.16M | -18.81M | -159.25M | -32.95M | -47.75M | -47.77M | -44.15M |
| Pre Tax Income | -18.44M | -18.78M | -18.46M | -217.07M | -40.1M | -63.18M | -43.83M | -38.84M |
| Net Income | -18.23M | -18.82M | -18.42M | -217.08M | -40.16M | -63.13M | -43.86M | -38.84M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -18.73M | -19.17M | -18.88M | -159.25M | -16.08M | -65.04M | -48.26M | -44.76M |
| EBITDA | -18.35M | -18.94M | -18.42M | -158.89M | -32.95M | -47.75M | -47.77M | -44.15M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.63M | 5.21M | 3.89M | 0 | 0 | 18.74M | 2.33M | 886k |
| Operating Income | -21.91M | -27.68M | -45.46M | -80.33M | -81.48M | -65.65M | -84.78M | -258.75M |
| Pre Tax Income | -21.7M | -27.24M | -44.35M | -78.25M | -80.89M | -65.66M | -83.95M | -338.82M |
| Net Income | -21.7M | -27.24M | -44.35M | -78.25M | -80.89M | -65.8M | -83.82M | -338.79M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.968 | -1.062 | -1.339 | -2.056 | -1.421 | -1.128 | -1.189 | -26.017 |
| EBIT | -21.94M | -27.72M | -45.52M | -80.4M | -81.49M | -65.77M | -84.79M | -261.43M |
| EBITDA | -21.77M | -27.43M | -45.17M | -79.92M | -80.49M | -64.07M | -83.38M | -258.01M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
